Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Filed Chapter 11
Director departure
Appointed director
Quarterly results
K-V Pharmaceutical Co (KV.A) Create: Alert

All | News | Filings
Date FiledTypeDescription
03/05/2014 4 Form 4 - Statement of changes in beneficial ownership of securities
03/05/2014 4 Christmas Patrick J. (General Counsel) has filed a Form 4 on K-V Pharmaceutical Co
03/05/2014 4 Nielson Steven (Director) has filed a Form 4 on K-V Pharmaceutical Co
03/05/2014 4 McInnis Joe (Director) has filed a Form 4 on K-V Pharmaceutical Co
03/05/2014 4 Vergis Janet S. (Director) has filed a Form 4 on K-V Pharmaceutical Co
03/05/2014 4 MCHUGH THOMAS S (CFO) has filed a Form 4 on K-V Pharmaceutical Co
03/05/2014 4 Goldfarb James M. (Director) has filed a Form 4 on K-V Pharmaceutical Co
03/05/2014 4 Norden Gregory (Director) has filed a Form 4 on K-V Pharmaceutical Co
03/05/2014 4 DIVIS GREG J (CEO and President) has filed a Form 4 on K-V Pharmaceutical Co
11/20/2013 4 Silver Point Capital L.P. (10% Owner) has filed a Form 4 on K-V Pharmaceutical Co
Txns: Bought 25,000 shares @ $46.5, valued at $1.2M
11/15/2013 4 Silver Point Capital L.P. (10% Owner) has filed a Form 4 on K-V Pharmaceutical Co
Txns: Bought 57,162 shares @ $42.75, valued at $2.4M
Bought 50,000 shares @ $44.5, valued at $2.2M
11/01/2013 4 Vergis Janet S. (Director) has filed a Form 4 on K-V Pharmaceutical Co
Txns: Granted 15,000 options to buy @ $28.8, valued at $432k
Granted 5,000 options to buy @ $32, valued at $160k
Granted 3,751 restricted stock units @ $0
10/25/2013 4 MAHADY JOSEPH M (Director) has filed a Form 4 on K-V Pharmaceutical Co
10/23/2013 4 Goldfarb James M. (Director) has filed a Form 4 on K-V Pharmaceutical Co
Txns: Granted 15,000 options to buy @ $28.8, valued at $432k
Granted 5,000 options to buy @ $32, valued at $160k
Granted 3,751 restricted stock units @ $0
10/23/2013 4 Norden Gregory (Director) has filed a Form 4 on K-V Pharmaceutical Co
Txns: Granted 15,000 options to buy @ $28.8, valued at $432k
Granted 5,000 options to buy @ $32, valued at $160k
Granted 3,751 restricted stock units @ $0
10/04/2013 4 Christmas Patrick J. (General Counsel) has filed a Form 4 on K-V Pharmaceutical Co
Txns: Granted 86,806 restricted stock units @ $0
Granted 40,327 options to buy @ $20, valued at $806.5k
10/04/2013 4 MCHUGH THOMAS S (CFO) has filed a Form 4 on K-V Pharmaceutical Co
Txns: Granted 86,806 restricted stock units @ $0
Granted 40,327 options to buy @ $20, valued at $806.5k
10/04/2013 4 DIVIS GREG J (CEO and President) has filed a Form 4 on K-V Pharmaceutical Co
Txns: Granted 173,611 restricted stock units @ $0
Granted 80,653 options to buy @ $20, valued at $1.6M
09/27/2013 4 Stancic Ana (Director) has filed a Form 4 on K-V Pharmaceutical Co
Txns: Disposed of 10,000 options to buy @ $1.62, valued at $16.2k
Disposed of 7,500 options to buy @ $1.14, valued at $8.6k
Disposed of 20,000 options to buy @ $1.49, valued at $29.8k
Disposed of 20,000 options to buy @ $0.94, valued at $18.8k
09/27/2013 4 BALDINI ROBERT E (Director) has filed a Form 4 on K-V Pharmaceutical Co
09/27/2013 4 Silver Point Capital L.P. (10% Owner) has filed a Form 4 on K-V Pharmaceutical Co
Txns: Sold 199,000 shares @ $40, valued at $8M
09/26/2013 4 Dow Mark A. (Director) has filed a Form 4 on K-V Pharmaceutical Co
09/26/2013 4 BENTLEY GREGORY SMITH (Director) has filed a Form 4 on K-V Pharmaceutical Co
09/26/2013 4 Hermelin David S (Director) has filed a Form 4 on K-V Pharmaceutical Co
09/25/2013 4 Silver Point Capital L.P. (10% Owner) has filed a Form 4 on K-V Pharmaceutical Co
Txns: Bought 150,000 shares @ $40, valued at $6M
09/24/2013 4 Christmas Patrick J. (General Counsel) has filed a Form 4 on KV PHARMACEUTICAL CO /DE/
Txns: Disposed of 40,000 options to buy @ $3.32, valued at $132.8k
Disposed of 40,000 options to buy @ $1.32, valued at $52.8k
09/20/2013 4 SIDRANSKY DAVID (Director) has filed a Form 4 on KV PHARMACEUTICAL CO /DE/
Txns: Disposed of 1,000 shares @ $0
Disposed of 10,000 options to buy @ $1.62, valued at $16.2k
Disposed of 7,500 options to buy @ $1.02, valued at $7.7k
Disposed of 20,000 options to buy @ $1.49, valued at $29.8k
Disposed of 20,000 options to buy @ $0.94, valued at $18.8k
09/19/2013 4 LEHRER JOSEPH D (Director) has filed a Form 4 on KV PHARMACEUTICAL CO /DE/
09/18/2013 4 MCHUGH THOMAS S (CFO) has filed a Form 4 on KV PHARMACEUTICAL CO /DE/
Txns: Disposed of 20,000 options to buy @ $1.4, valued at $28k
Disposed of 5,000 options to buy @ $1.52, valued at $7.6k
Disposed of 20,000 options to buy @ $1.62, valued at $32.4k
Disposed of 25,000 options to buy @ $1.14, valued at $28.5k
Disposed of 35,000 options to buy @ $1.49, valued at $52.2k
Disposed of 35,000 options to buy @ $1.32, valued at $46.2k
09/18/2013 4 DIVIS GREG J (CEO and President) has filed a Form 4 on KV PHARMACEUTICAL CO /DE/
Txns: Disposed of 1,225 shares @ $0
Disposed of 28,775 options to buy @ $28.6, valued at $823k
Disposed of 70,000 options to buy @ $2.95, valued at $206.5k
Disposed of 10,000 options to buy @ $1.52, valued at $15.2k
Disposed of 50,000 options to buy @ $1.62, valued at $81k
Disposed of 70,000 options to buy @ $1.49, valued at $104.3k
Disposed of 100,000 options to buy @ $1.32, valued at $132k
08/07/2013 4 GLENVIEW CAPITAL MANAGEMENT, LLC (10% Owner) has filed a Form 4 on KV PHARMACEUTICAL CO /DE/
Txns: Bought 1,764,709 shares @ $0.4649, valued at $820.4k
08/05/2013 4 GLENVIEW CAPITAL MANAGEMENT, LLC (10% Owner) has filed a Form 4 on KV PHARMACEUTICAL CO /DE/
Txns: Bought 800,000 shares @ $0.58, valued at $464k
Bought 703,000 shares @ $0.55, valued at $386.7k
02/07/2013 4 Parkside Financial Bank & Trust (10% Owner) has filed a Form 4 on KV PHARMACEUTICAL CO /DE/
05/16/2012 4 LEHRER JOSEPH D (Director) has filed a Form 4 on KV PHARMACEUTICAL CO /DE/
Txns: Granted 30,000 options to buy @ $0.94, valued at $28.2k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy